Type iii secretion system antigens from bordetella pertussis
CA 2356764 A1 · Owner: Fauconnier, Alain · Inventors: Bollen, Alex; Godfroid, Edmond; Fauconnier, Alain
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to a general method for detecting pathogenic strains of bacteria which harbour a type III secretion system. More particularly this , invention relates to the methods as applied to the pathogen <i>Bordetella pertussis</i>. Furthermore, the invention relates to newly identified polynucleotides within these regions, virulent polypeptides encoded by them and to the use of such polynucleotides and polypeptides and to their , production. More particularly the polynucleotides and polypeptides of the present invention relate to the virulent effector proteins associated with the type III secretion system of <i>Bordetella pertussis</i> which are , particularly suitable …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 21, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 21, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 21, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.